Greg Weaver has been named chief financial officer of Talyst, a Bellevue, Wash.-based provider of pharmacy bar coding, packaging and inventory software and equipment. He replaces Tom Virgin, who is now the CFO at HipCricket, a Bellevue, Wash.-based interactive marketing firm.
Previously, Weaver, 51, was senior vice president and CFO of Sirna Therapeutics, a San Francisco-based biotechnology company acquired by Merck in 2006. He has also held CFO positions for Bothell, Wash.-based Nastech Pharmaceuticals and Ilex Oncology, a San Antonio-based biopharmaceutical company acquired by Genzyme in 2004. -- by Andis Robeznieks / HITS staff writer
Making news? Send your personal and personnel healthcare IT news to [email protected]. Please attach a color photo of your HITS News Maker with your submission.